Cerium Oxide Nanoparticles with Entrapped Gadolinium for High T ₁ Relaxivity and ROS-Scavenging Purposes

Area of Science:

• Nanotechnology
• Materials Science
• Radiology
• Biomedical Engineering

Background:

• Current gadolinium-based contrast agents for MRI have raised safety concerns.
• There is a need for next-generation contrast agents with improved T1 relaxivity and stability.
• Linear gadolinium chelates, while widely used, are under scrutiny.

Purpose of the Study:

• To develop a novel, stable nanoparticulate contrast agent for MRI.
• To enhance T1 relaxivity at lower doses compared to existing agents.
• To investigate the potential of the new agent as a scavenger of reactive oxygen species (ROS).

Main Methods:

• Integration of gadolinium ions into cerium oxide nanoparticles (5 nm size).
• Characterization of nanoparticle structure, gadolinium distribution, and oxidation states (Ce3+/Ce4+).
• In vivo bioluminescent imaging to assess ROS-scavenging capabilities.

Main Results:

• A stable, crystalline 5 nm cerium oxide nanoparticle system with homogeneous gadolinium distribution was synthesized.
• The gadolinium-containing nanoparticles exhibited strong T1 relaxivity (r1 = 12.0 mM−1 s−1).
• The nanoparticles demonstrated significant ROS-scavenging properties, attributed to Ce3+ sites and oxygen vacancies on the surface.

Conclusions:

• Gadolinium-integrated cerium oxide nanoparticles represent a promising next-generation MRI contrast agent.
• These nanoparticles offer enhanced T1 relaxivity and potent antioxidant capabilities.
• The dual functionality suggests potential for combined diagnostic and therapeutic applications.